Targeted ATG Dosing Pilot Study
Matched Unrelated Donor and Partially Matched Related Donor Peripheral Stem Cell Transplantation With Alpha/Beta T-Cell and B-Cell Depletion for Patients With Hematologic Malignancies With Targeted ATG Dosing Pilot Study, IDE 13641
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 0
- Enrollment
- 40 patients (estimated)
- Sponsors
- Medical College of Wisconsin
- Tags
- Allogeneic Stem Cell Transplant
- Trial Type
- Treatment
- Last Update
- 9 months ago
- SparkCures ID
- 1867
- NCT Identifier
- NCT05794880
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.